Best Melasma Treatment
The most effective first-line treatment for melasma is triple combination cream containing hydroquinone 4%, tretinoin 0.05%, and a corticosteroid (typically fluocinolone acetonide 0.01%), combined with strict broad-spectrum photoprotection. This remains the only FDA-approved treatment and gold standard across all skin types 1, 2, 3.
First-Line Treatment Algorithm
Core Topical Therapy (Minimum 3 months)
- Triple combination cream (hydroquinone + tretinoin + corticosteroid) applied nightly
- Use continuously for 8-12 weeks initially 4, 3
- Expect approximately 40% of patients to develop erythema and peeling—this is manageable and does not require discontinuation 5
Essential Photoprotection
- Broad-spectrum sunscreen containing zinc oxide, iron oxide, and titanium dioxide applied daily 1, 3
- Physical sunscreens provide both photoprotective and camouflage effects
- This is non-negotiable regardless of other treatments used
Add Oral Tranexamic Acid if No Contraindication
- 250 mg twice daily for moderate to severe or recalcitrant cases 6, 3
- Multiple studies show intradermal PRP was superior to tranexamic acid injections for melasma severity scores 7, but oral tranexamic acid remains a proven systemic adjunct
- Screen for thromboembolic risk factors before prescribing
Alternative First-Line Options (If Hydroquinone Contraindicated)
When hydroquinone cannot be used:
- Azelaic acid or kojic acid 2% as topical alternatives 8, 3
- Cysteamine 5% cream shows comparable effectiveness to kojic acid with good tolerability 8
- These alternatives minimize irritation, erythema, and avoid exogenous ochronosis risk
Second-Line Procedural Therapies
Add these only after 3 months of optimized topical therapy:
- Chemical peels (glycolic acid or TCA) as adjuncts to topical therapy 6
- Microneedling can enhance transdermal delivery 7
- Peels alone are NOT superior to topical therapy and should not replace it 6
Third-Line: Laser Therapy (Refractory Cases Only)
Reserve for cases failing topical + oral therapy:
- Low-fluence Q-switched Nd:YAG laser (best option, especially for darker skin types) 6
- Picosecond laser shows excellent results 6
- Pulsed dye laser for lighter skin types only 6
- Lasers carry higher risk of post-inflammatory hyperpigmentation, particularly in Fitzpatrick types IV-VI 2, 4
Emerging Adjunctive Option: Autologous Platelet Concentrates (APCs)
Recent 2025 guidelines show promising data for PRP/PRF [7-7]:
- Intradermal PRP injections demonstrated significantly better mMASI score reductions compared to tranexamic acid injections in multiple studies 7
- PRP works best when combined with effective home care and sun protection 7
- Microneedling delivery may be more effective than intradermal injections 7
- However, one 2026 study found PRP added to microneedling radiofrequency did NOT improve global pigment scores beyond the device alone, though VISIA analysis showed benefit for erythema and brown spots 9
The evidence for APCs is mixed and protocols remain unstandardized 7. This should be considered an adjunctive or alternative option, not first-line.
Maintenance Strategy
Melasma must be managed as a chronic condition requiring long-term maintenance 7:
- After initial 12-week treatment, switch to maintenance with non-hydroquinone products or intermittent triple combination (twice weekly or less) 4
- Continue photoprotection indefinitely
- Monthly follow-ups initially to assess compliance, tolerance, and efficacy 4
- Regular follow-ups long-term to prevent relapse 7
Critical Pitfalls to Avoid
Starting lasers or peels before adequate topical therapy trial—this increases post-inflammatory hyperpigmentation risk, especially in darker skin 2, 4, 5
Inadequate photoprotection counseling—UV exposure is a primary trigger; treatment will fail without strict sun protection 7, 3
Discontinuing treatment too early—melasma requires minimum 3 months of consistent therapy before assessing efficacy 6, 4
Not offering camouflage—cosmetic camouflage should be offered at any treatment stage to address quality of life impact 4
Ignoring hormonal triggers—high-dose oral estrogen HRT has documented association with melasma, particularly in Fitzpatrick types III-VI; counsel at-risk women appropriately 10